Respiree announced today that it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai (‘JLABS’) from February 21, 2023 , in order to expand its footprint with the goal of deepening its relationships and networks within the pharma and life science sector.
Digital therapeutics startup Respiree™ gains US FDA approval for its RS001 cardio-respiratory wearable
Digital therapeutics startup Respiree has received the United States Food and Drug Administration’s 510(k) clearance for its RS001 cardio-respiratory wearable.
Patients warded in Changi General Hospital could have their vital signs checked remotely in the future
The device could save up to 12 man-hours daily, allowing nurses to focus on other aspects of a patient’s well-being.
Changi General Hospital partners Respiree to advance patient care through smart remote monitoring of vital signs
Changi General Hospital partners Respiree to advance patient care through smart remote monitoring of vital signs: Potential for wearable medical sensor to maximise and improve productivity gains